Acrodermatitis enteropathica is a rare inherited disorder that prevents the body from absorbing zinc properly, leading to a recognizable pattern of skin rashes around the mouth and other body openings, chronic diarrhea, and hair loss. It is caused by mutations in the gene that codes for a zinc transporter in the small intestine, and without treatment it can be fatal. The condition is treatable with lifelong oral zinc supplements, but its rarity and its resemblance to other skin diseases mean it is sometimes missed or diagnosed late, with consequences that go well beyond the skin.
The Classic Triad and How It Appears
The hallmark presentation of acrodermatitis enteropathica is a triad of periorificial dermatitis, alopecia, and diarrhea. “Periorificial” means the rash clusters around body openings: the mouth, eyes, nostrils, ears, and the diaper area in infants. The lesions also appear on the hands, feet, elbows, and knees. They typically start as red, scaly, crusted patches that can blister and erode, sometimes becoming superinfected with bacteria or yeast.1PubMed Central. Acrodermatitis Enteropathica: A Case Report The diarrhea can be watery or fatty, and the hair loss affects the scalp and sometimes the eyebrows and eyelashes.
In the inherited form, symptoms usually surface after an infant is weaned from breast milk. Breast milk contains zinc bound to a protein that aids absorption through a pathway that partially bypasses the defective transporter, so exclusively breastfed infants may be protected for weeks or months. Once breast milk is replaced with formula or solid food, the zinc deficit becomes apparent quickly. Skin lesions and irritability often appear within days to weeks of weaning.
Beyond the classic three symptoms, infants frequently show mood changes, irritability, loss of appetite, and neurological disturbances.2PubMed. Clinical and laboratory diagnosis of acrodermatitis enteropathica Older children and adults who have undiagnosed or undertreated disease may present with less obvious skin findings but persistent fatigue, poor wound healing, and recurrent infections.
What Goes Wrong at the Genetic Level
The condition traces to mutations in a gene called SLC39A4, which encodes a zinc transporter protein known as ZIP4. ZIP4 sits on the surface of cells lining the small intestine, where its job is to pull dietary zinc from the gut into the body. The disorder follows an autosomal recessive inheritance pattern, meaning a child needs two defective copies of SLC39A4, one from each parent, to develop disease.3PubMed Central. Regulation and function of Zip4, the acrodermatitis enteropathica gene Parents who each carry one mutated copy are typically healthy because a single working copy produces enough functional ZIP4 to absorb zinc normally.
Dozens of different mutations in SLC39A4 have been identified in affected families. Some are missense mutations that produce a transporter that folds incorrectly or traffics to the wrong part of the cell; others are nonsense or splice-site mutations that prevent any functional protein from being made at all. The specific mutation can influence how severe the disease is and, in rare cases, how well a patient responds to standard treatment.4PubMed Central. A Zinc Sulphate-Resistant Acrodermatitis Enteropathica Patient with a Novel Mutation in SLC39A4 Gene
Among the many zinc transporters expressed in the intestine, ZIP4 is uniquely important for moving dietary zinc into the bloodstream. Research in mice showed that ZIP4 expression in the small intestine was the only transporter that reliably predicted how much zinc ended up in the liver and plasma after a meal.5PubMed. Slc39a4 in the small intestine predicts zinc absorption and utilization That helps explain why losing ZIP4 function is so devastating: no other transporter can compensate for it in a meaningful way.
Why Zinc Deficiency Damages So Many Systems
Zinc is a cofactor for hundreds of enzymes and plays structural roles in thousands of proteins throughout the body. When the gut cannot absorb it, the deficiency ripples outward. The skin, gut lining, and immune system are hit hardest because they are tissues that turn over rapidly and depend heavily on zinc-dependent processes for cell division, DNA repair, and protein synthesis.
Mouse models that delete ZIP4 specifically in the intestine develop wasting, intestinal breakdown, and death that closely mirrors the human disease. The research showed that losing ZIP4 disrupted the stem cell niche in the intestinal lining and altered the behavior of Paneth cells, which are key regulators of gut immunity and stem cell maintenance.6PLOS Genetics. A Mouse Model of Acrodermatitis Enteropathica: Loss of Intestine Zinc Transporter ZIP4 (Slc39a4) Disrupts the Stem Cell Niche and Intestine Integrity In plain terms, without ZIP4 the gut loses its ability to repair and renew itself, which compounds the malabsorption and leads to a downward spiral of worsening diarrhea, nutrient loss, and tissue damage.
Immune Suppression and Recurrent Infections
One of the more dangerous aspects of untreated acrodermatitis enteropathica is the immune suppression it causes. Affected children are prone to bacterial, fungal, and viral infections that can become life-threatening. Before the condition was understood and treated, secondary infections were a leading cause of death.
Studies documented that patients with acrodermatitis enteropathica had depressed numbers of T cells, abnormal responses to immune stimulation tests, and a failure to react to standard skin-test antigens, all signs of impaired cell-mediated immunity.7American Journal of Diseases of Children. Zinc Therapy of Depressed Cellular Immunity in Acrodermatitis Enteropathica: Its Correction Autopsy observations in fatal cases revealed shrunken thymus glands, underdeveloped tonsils, and depleted immune tissue in the gut.8Pediatrics. Acrodermatitis Enteropathica: Zinc Levels and Cell-Mediated Immunity Opportunistic infections with organisms like Candida were common, sometimes mimicking primary immune deficiency disorders and leading clinicians down the wrong diagnostic path.
The good news is that zinc supplementation reversed the immune deficits. After treatment, T cell counts, mitogen responses, and skin-test reactivity all returned to normal, confirming that the immune suppression was a downstream effect of zinc deficiency rather than an intrinsic immune disorder.9American Journal of Diseases of Children. Zinc Therapy of Depressed Cellular Immunity in Acrodermatitis Enteropathica: Its Correction
Diagnosis and What Makes It Tricky
Diagnosing acrodermatitis enteropathica starts with recognizing the clinical pattern: the right kind of rash in the right places, combined with diarrhea and hair loss in a young child. A low serum zinc level supports the diagnosis, and a rapid clinical response to zinc supplementation essentially confirms it. Genetic testing for SLC39A4 mutations can provide definitive confirmation and is useful for family counseling.
The trouble is that the classic triad does not always appear simultaneously, and skin findings can be mistaken for eczema, psoriasis, candidiasis, or other common dermatologic conditions. In one reported case, a patient underwent multiple hospitalizations and was treated with corticosteroids before the correct diagnosis of acquired zinc deficiency was finally made based on a low serum zinc level and a positive response to supplementation.10BioMed Central. Adult autoimmune enteropathy presenting initially with acquired Acrodermatitis Enteropathica: a case report
Laboratory markers beyond serum zinc can be helpful. Serum alkaline phosphatase is a zinc-dependent enzyme, and studies showed a strong positive correlation between serum zinc and alkaline phosphatase levels in patients on zinc treatment, meaning a falling alkaline phosphatase can serve as a warning sign of declining zinc status before the skin lesions reappear.11Acta Dermato-Venereologica. Serum alkaline phosphatase activity in acrodermatitis enteropathica: an index of the serum zinc level This is especially useful for monitoring treatment because serum zinc levels alone can fluctuate with meals and sample handling.
Growth, Eyes, and Other Underappreciated Effects
Children with poorly controlled acrodermatitis enteropathica often fall behind in height and weight. Research found that the short stature seen in these patients was related to their nutritional state and the severity and duration of untreated disease, not an inherent feature of the genetic condition itself. Starting effective zinc therapy early largely prevented or reversed the growth deficit.12JAMA Dermatology. Acrodermatitis Enteropathica and Failure to Thrive This finding underscores how much early diagnosis matters: the longer a child goes without adequate zinc, the harder it becomes to catch up developmentally.
Ocular involvement is rarely discussed but has been documented. A case of a six-month-old infant showed bilateral corneal clouding, photophobia, and conjunctivitis alongside the typical skin lesions and diarrhea. The eye findings improved dramatically after zinc supplementation was started.13PubMed Central. Acrodermatitis enteropathica with ocular manifestations Other reported ocular findings include blepharitis and superficial keratitis. Because zinc plays a role in the structure and function of the corneal epithelium, these complications make biological sense, but they are easy to overlook if the examining physician is not aware they can occur in zinc deficiency.
Treatment With Zinc Supplements
The standard treatment is straightforward: oral zinc supplementation, usually as zinc sulfate, taken for life. In adults, early clinical work demonstrated that oral zinc sulfate produced rapid and complete resolution of all skin lesions, normalized plasma zinc levels, and restored normal alkaline phosphatase and urinary zinc excretion.14PubMed. Zinc therapy of acrodermatitis enteropathica In children, doses are typically calculated by body weight. One reported case used an initial dose of about 10 mg per kilogram per day, which cleared the skin lesions completely. After six months of follow-up with normalized zinc levels, the dose was gradually tapered to a maintenance level of about 2 to 4 mg per kilogram per day.15PubMed Central. Acrodermatitis Enteropathica: A Rare Case With Lifelong Implications
The response to treatment can be remarkably fast. Skin improvement often begins within days, and diarrhea and mood changes can resolve within the first week. This rapid turnaround is one reason clinicians sometimes use a “therapeutic trial” of zinc as a diagnostic tool: if the rash clears within a few days of starting zinc, the diagnosis is essentially confirmed.
There are exceptions, though. Some patients experience relapses during adolescence even while on consistent therapy, likely because the zinc demands of puberty and rapid growth outstrip what their current dose provides. More rarely, individual mutations in SLC39A4 appear to produce a form of disease that is resistant to standard zinc sulfate doses. One case report described a 13-year-old girl whose disease did not respond to high-dose zinc sulfate, prompting investigation of her specific mutation and consideration of alternative zinc preparations.16PubMed Central. A Zinc Sulphate-Resistant Acrodermatitis Enteropathica Patient with a Novel Mutation in SLC39A4 Gene
The Copper Problem With Long-Term Zinc Therapy
One complication that can sneak up on patients and their doctors is copper deficiency. Zinc and copper compete for the same absorption pathways in the gut, and taking high doses of zinc over months or years can gradually deplete copper stores. In one case, a 23-year-old man with acrodermatitis enteropathica developed anemia and a dangerous drop in white blood cells after 12 months on high-dose zinc sulfate. Investigation revealed severely low copper and ceruloplasmin levels. Stopping the zinc and providing intravenous copper corrected the anemia and restored normal blood counts.17Science of The Total Environment. Copper responsive anemia, induced by oral zinc therapy in a patient with acrodermatitis enteropathica
A separate study found that patients on higher zinc doses developed low copper status along with measurable immune dysfunction, and that simply lowering the zinc dose normalized both copper levels and immune markers.18Archives of Pediatrics & Adolescent Medicine. Acrodermatitis Enteropathica, Zinc Metabolism, Copper Status, and Immune Function The irony is worth noting: the very treatment that restores immune function in zinc-deficient patients can, at excessive doses, suppress it again through a different mechanism. This is why periodic monitoring of copper status is recommended for anyone on lifelong zinc supplementation.
The Look-Alike Condition in Breastfed Babies
Transient neonatal zinc deficiency is a distinct condition that can mimic acrodermatitis enteropathica almost exactly, down to the same rash pattern, diarrhea, and hair thinning. The difference is that it affects exclusively breastfed infants whose mothers produce breast milk with abnormally low zinc content, typically because of mutations in a different gene, SLC30A2, which encodes a zinc transporter called ZnT2 that moves zinc into breast milk.19PubMed Central. Novel SLC30A2 mutations in the pathogenesis of transient neonatal zinc deficiency
The zinc content in affected mothers’ milk can be reduced by 75% or more. In one case, a Japanese mother carrying compound mutations in SLC30A2 had milk zinc levels reduced by over 90%, and her breastfed infant developed severe zinc deficiency.20PLoS ONE. Compound Heterozygous Mutations in SLC30A2/ZnT2 Results in Low Milk Zinc Concentrations Unlike acrodermatitis enteropathica, the infant’s own zinc absorption machinery works perfectly well. The problem is that the supply is deficient. These babies improve with zinc supplementation or with switching to formula, and once weaned they typically do not need further treatment.
Distinguishing the two conditions matters for family planning and long-term management. A baby with transient neonatal zinc deficiency does not carry SLC39A4 mutations and will not need lifelong zinc. The mother, however, may produce zinc-deficient milk in subsequent pregnancies, so future breastfed siblings could be at risk. Genetic testing can clarify which gene is involved and guide counseling.
Acquired Zinc Deficiency That Mimics the Genetic Disease
Adults who have never had acrodermatitis enteropathica can develop an identical-looking condition if their zinc levels drop severely for other reasons. This is sometimes called “acquired acrodermatitis enteropathica” or “acrodermatitis enteropathica-like syndrome.” The causes include malabsorptive conditions like Crohn’s disease, celiac disease, or autoimmune enteropathy, as well as chronic alcoholism, bariatric surgery, prolonged parenteral nutrition without zinc supplementation, and certain medications that bind zinc.
In one documented case, a 41-year-old woman presented with months of worsening skin lesions, diarrhea, hair loss, and weight loss. She was diagnosed with acquired zinc deficiency and initially responded to zinc supplementation. But because her levels kept dropping despite aggressive supplementation, further investigation uncovered an underlying autoimmune enteropathy that was causing malabsorption across the board.21BioMed Central. Adult autoimmune enteropathy presenting initially with acquired Acrodermatitis Enteropathica: a case report The lesson is that while zinc supplementation treats the immediate symptoms, an acquired presentation in an adult should always prompt a search for an underlying cause of malabsorption.
An Animal Model That Mirrors the Human Disease
Acrodermatitis enteropathica has a naturally occurring counterpart in cattle. A condition known as lethal trait A46, or bovine hereditary zinc deficiency, was first described in 1964. Affected calves develop skin lesions, diarrhea, wasting, and immune deficiency that closely parallel the human disease. The bovine condition was traced to a splice-site mutation in the same SLC39A4 gene, confirming that the genetic and biological basis is conserved across species.22PubMed. Identification of a unique splice site variant in SLC39A4 in bovine hereditary zinc deficiency, lethal trait A46 The bovine model, along with the intestine-specific ZIP4 knockout mouse, has been valuable for understanding how the loss of this single transporter cascades into multi-organ disease.
Pregnancy in Women With the Condition
Because acrodermatitis enteropathica requires lifelong treatment, questions about pregnancy management arise naturally. Zinc demands increase during pregnancy, and inadequate zinc status is associated with complications including preterm delivery and low birth weight. Women with the condition need careful monitoring and dose adjustment throughout pregnancy to ensure that serum zinc levels remain adequate for both maternal health and fetal development. Case reports have documented successful pregnancies in women with acrodermatitis enteropathica maintained on zinc sulfate therapy, though published data on this topic remain limited to small case series.23PubMed Central. Two pregnancies in a patient with acrodermatitis enteropathica treated with zinc sulphate The key practical point is that zinc supplementation should not be interrupted during pregnancy, and doses may need to go up rather than down.
For families planning children, genetic counseling is worthwhile. Since the condition is autosomal recessive, both parents must carry a mutated copy of SLC39A4 for a child to be affected. If one parent has the disease and the other is not a carrier, their children will all be carriers but none will have symptoms. If both parents are carriers, each pregnancy carries roughly a one-in-four chance of producing an affected child. Carrier testing and prenatal genetic diagnosis are available for families with a known mutation.